EP3178472
ORAL FORMULATIONS OF METHYLNALTREXONE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.3.2011EP published:
27.10.2021EP application number:
17153285.6
EPO information:
European Patent Register
Max expiry date:
10.3.2031
Title:
ORAL FORMULATIONS OF METHYLNALTREXONE
Timeline
Today
11.3.2011EP application
27.10.2021EP Publication
Owner
Name:
Wyeth LLCAddress:
Five Giralda Farms, Madison, NJ 07940, US
Inventor
Name:
Shah, Syed M.Address:
East Hanover, NJ New Jersey 07936, US
Name:
Diorio, Christopher RichardAddress:
Campbell Hall, NJ New Jersey 10916, US
Name:
Ehrnsperger, Eric C.Address:
New City, NY New York 10956, US
Name:
Meng, XuAddress:
San Diego, CA California 92130, US
Name:
Shareffi, Kadum A.Address:
Congers, NY New York 10920, US
Name:
Cohen, Jonathan MarcAddress:
Monroe, NY New York 10950, US
Priority
Number:
313018 PDate:
11.3.2010Country:
US
Classification
Categories:
A61K 9/20, A61K 31/485, C07D 489/08, A61P 1/00, A61P 1/08, A61P 1/10, A61P 1/14, A61P 25/04